Medical oncologist Dr. Jeffrey S. Weber discusses milestones in the development of immunotherapies for melanoma.
Photo: Karsten Moran
The development of immunotherapies called checkpoint inhibitors to treat melanoma has changed the way doctors approach the disease. Jeffrey S. Weber, MD, PhD, deputy director of 嘿嘿视频鈥檚 Perlmutter Cancer Center, was at the forefront of this effort and continues to lead in an effort to improve treatments for this disease, which is the deadliest form of skin cancer.
Dr. Weber spoke with OncLive On Air about the path that led him to treat people who have cancer and melanoma specifically, his own research to develop immunotherapies for melanoma, and what lies ahead for people with advanced melanoma.
鈥淟ooking ahead, I think that we have to do a better job at having biomarkers and picking the patients who would be most likely to benefit from treatment,鈥 says Dr. Weber, who is also co-director of 嘿嘿视频鈥檚 .
Listen to Dr. Weber鈥檚 entire interview with .
